It achieves this by facilitating cancer cell survival, migration, metastasis, chemoresistance, and evasion of immune responses, particularly in response to immunosuppressive agents like programmed cell death protein 1 (PD1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) [18–20]. This evidence concerns the gene PDCD1 and cancer.